STOCK TITAN
  1. Home
  2. Sec-filings
  3. EXC
  4. [Form 4] EXELON CORP Insider Trading Activity

Director at Exelon (EXC) granted 3,720 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Exelon Corp director Matthew C. Rogers received an annual equity award of 3,720 restricted stock units for 2026 board service. These 2026 Directors Restricted Stock Units were granted at a $0.00 exercise price under the Exelon Long-term Incentive Plan and will fully vest and be settled in Exelon common shares on a 1-for-1 basis on April 28, 2027. The award will accumulate additional stock units through dividend reinvestment that vest with the underlying grant.

The filing also notes 739 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when Rogers’ service on Exelon’s board ends, rather than through open-market stock transactions.

Positive

  • None.

Negative

  • None.
Insider Rogers Matthew C
Role null
Type Security Shares Price Value
Grant/Award 2026 Directors Restricted Stock Units 3,720 $0.00 --
holding Deferred phantom share equivalents -- -- --
Holdings After Transaction: 2026 Directors Restricted Stock Units — 3,720 shares (Direct, null); Deferred phantom share equivalents — 739 shares (Direct, null)
Footnotes (1)
  1. Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
RSUs granted 3,720 units 2026 Directors Restricted Stock Units granted April 28, 2026
RSU exercise price $0.00 per unit Grant under Exelon Long-term Incentive Plan
RSU vesting/settlement date April 28, 2027 Units settle 1-for-1 into Exelon common stock
Deferred phantom share equivalents 739 units Value tracked to Exelon common stock, settled in cash 1-for-1
Underlying common stock for RSUs 3,720 shares Each RSU converts into one Exelon common share at vesting
restricted stock unit (RSU) financial
"Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP)"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
Long-term Incentive Plan (LTIP) financial
"award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest"
phantom share equivalents financial
"Phantom share equivalents held in the reporting person's Exelon stock fund account"
non-qualified deferred compensation plan financial
"part of a multi-fund, non-qualified deferred compensation plan"
An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rogers Matthew C
(Last)(First)(Middle)
10 S DEARBORN STREET
54TH FLOOR
(Street)
CHICAGO ILLINOIS 60603
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
2026 Directors Restricted Stock Units(1)04/28/2026A3,72004/28/202704/28/2027Common Stock3,720$03,720D
Deferred phantom share equivalents(2) (2) (2)Common Stock739739D
Explanation of Responses:
1. Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award.
2. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
Remarks:
David T Skinner, attorney-in-fact for Matthew C Rogers04/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity award did Exelon (EXC) director Matthew C. Rogers receive?

Matthew C. Rogers received 3,720 2026 Directors Restricted Stock Units as an annual equity award. These units were granted at a $0.00 exercise price under Exelon’s Long-term Incentive Plan and will settle in Exelon common stock on a 1-for-1 basis when they vest.

When do Matthew C. Rogers’ 2026 Exelon (EXC) RSUs vest and settle?

The 3,720 2026 Directors Restricted Stock Units granted to Matthew C. Rogers vest and settle on April 28, 2027. At that time, each unit converts into one share of Exelon common stock, including additional units accumulated from dividend reinvestments linked to the original award.

How do dividend reinvestments affect the Exelon (EXC) RSU award?

The RSU award for Matthew C. Rogers accrues additional stock units through dividend reinvestment. When Exelon pays dividends, equivalent value is credited as extra units. These dividend-generated units vest at the same time and on the same terms as the original 3,720 restricted stock units.

What are the phantom share equivalents reported for Exelon (EXC) director Rogers?

The filing lists 739 deferred phantom share equivalents in Rogers’ Exelon stock fund account within a non-qualified deferred compensation plan. These track Exelon common stock but are settled in cash on a 1-for-1 basis when his service on the Exelon board terminates, not as share deliveries.

Are Matthew C. Rogers’ Exelon (EXC) phantom share equivalents settled in stock or cash?

Rogers’ 739 deferred phantom share equivalents are settled in cash, not stock. Each phantom equivalent mirrors one Exelon share in value and will pay out in cash on a 1-for-1 basis when his board service ends, according to the plan’s terms.